Insider transaction 📈 Stocks 🌍 United States

ICU Medical CFO Brian Bonnell Sells 6,381 Shares Worth $1.1 Million

ICU Medical CFO Brian Bonnell offloaded 6,381 shares in a scheduled 10b5-1 transaction, maintaining a significant $9.5 million equity position as the firm reports strong quarterly earnings growth.

📅 September 17, 2026 🕐 1 min read

1 assets impacted. Net bias: 0 Bullish, 0 Bearish, 1 Neutral. Strongest signal: ICUI → 2/10 (65% confidence).

📊 Affected Assets (1)

ICUI

Neutral 🤖 65%

📅 Short-term 🌍 US · Explicit

CFO sold 6,381 shares under a pre-arranged 10b5-1 trading plan, maintaining 56,062 shares, indicating routine portfolio diversification rather than opportunistic selling.

🎯 Key Takeaways

The $1.1 million share sale was executed via a pre-established Rule 10b5-1 plan, indicating routine diversification.
Bonnell retains 56,062 shares, maintaining significant alignment with the company's long-term performance.
ICU Medical recently raised its GAAP net income forecast to a range of $73 million to $83 million.

📝 Executive Summary

ICU Medical CFO Brian Bonnell executed a pre-arranged sale of 6,381 shares on September 1, 2026, valued at approximately $1.1 million. The transaction, conducted under a Rule 10b5-1 trading plan, leaves the executive with a remaining direct stake of 56,062 shares worth $9.5 million, signaling routine portfolio management rather than a shift in company outlook.

❓ FAQ

Why did the ICU Medical CFO sell shares?

The sale was part of a pre-arranged Rule 10b5-1 trading plan adopted in June 2026, which is a standard mechanism for insiders to sell stock without triggering concerns regarding material non-public information.

📰 Related Articles

🏷️ Tags

📰 Source

🔗 View Original Article